Rebound Hernia Repair Device Mesh Trial
Study Details
Study Description
Brief Summary
This is a post-market study of the Rebound Hernia Repair Device to further establish the safety, efficacy, and utility of the Rebound Hernia Repair Device in a controlled population. The Rebound Hernia Repair Device will be used for its approved indication in comparison to "standard" hernia mesh. Two-way students t-tests, Chi squared analysis and ANOVA will be used to detect differences in variables. The study is sufficiently powered to detect a 25% difference.
The study data will include quality of life assessments, visual analogue scale , SF-36, Carolinas Comfort Scale), recurrence of hernia (technical failure), use of medications (pain) and complications/adverse events.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 4 |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: The Rebound hernia repair device with no fixation Competent adults who have a unilateral, bilateral inguinal hernia that is primary in nature. |
Device: Rebound HRD
Laparoscopic TEP inguinal hernia repair using the Rebound HRD and no fixation
|
Active Comparator: Standard Hernia Mesh using fixation Competent adults who have a unilateral or bilateral inguinal hernia that is primary in nature. |
Device: Standard hernia mesh (VitaMesh)
Laparoscopic TEP inguinal hernia repair using standard hernia mesh with fixation
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Presence of hernia recurrence [2 years]
Secondary Outcome Measures
- Pain and discomfort to patients using VAS [2 years]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
18 to 80 years of age
-
Unilateral or bilateral inguinal hernia (moderate in size), primary in nature
Exclusion Criteria:
-
Unable to provide informed consent
-
Assessed as ASA 3 or 4
-
Renal failure;creatinine greater than 2.0mg percent
-
Ascites as determined by clinical suspicion/ultrasound confirmation
-
Known pregnancy
-
Femoral hernias
-
Diabetes requiring injectable insulin
-
Prior lower abdominal surgery through lower midline or Pfannenstiel incision
-
TAPP approach
-
Requiring anticoagulants during surgery
-
Participation in another study involving another device or drug
-
Emergent procedures for hernia incarceration and strangulation
-
Recurrent inguinal hernias
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University of Kentucky Dept. Of Surgery | Lexington | Kentucky | United States | 40536-0293 |
2 | The Ohio State Medical Center, Dept. of Surgery | Columbus | Ohio | United States | 43210-1228 |
Sponsors and Collaborators
- Minnesota Medical Development, Inc.
- University of Kentucky
- Ohio State University
Investigators
- Principal Investigator: John S Roth, MD, University of Kentucky
- Principal Investigator: Jeffrey W Hazey, MD, Ohio State University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- Rebound HRD